| Type | Public |
| HQ | Carlsbad, US |
| Founded | 2008 |
| Size (employees) | 91 (est) |
| Website | obalon.com |
Obalon Therapeutics was founded in 2008 and is headquartered in Carlsbad, US
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at Obalon Therapeutics
Mark Brister
VP of R&D
Nooshin Hussainy
Financial Controller
Report incorrect company information
Obalon Therapeutics Office Locations
Obalon Therapeutics has an office in Carlsbad
Carlsbad, US (HQ)
f 5421 Avenida Encinas
Report incorrect company information
Obalon Therapeutics Financials and Metrics
Obalon Therapeutics Revenue
Obalon Therapeutics's revenue was reported to be $9.91 m in FY, 2017
| USD | |
|---|---|
Revenue (Q2, 2018) | 4.1m |
Gross profit (Q2, 2018) | 1.6m |
Gross profit margin (Q2, 2018), % | 38.7% |
Net income (Q2, 2018) | (21.9m) |
EBIT (Q2, 2018) | (21.7m) |
Market capitalization (15-Oct-2018) | 51.2m |
Closing stock price (15-Oct-2018) | 2.2 |
Cash (30-Jun-2018) | 24.2m |
Obalon Therapeutics's current market capitalization is $51.2 m.
Annual
Annual
| USD | Y, 2018 |
|---|---|
Financial Leverage | 2 x |
Report incorrect company information
Obalon Therapeutics News and Updates
September 26, 2018
Global Intragastric Balloons Market 2018-2022 - Key Vendors are Allurion Technologies, Apollo Endosurgery, Helioscopie, Obalon Therapeutics, ReShape Lifesciences & Spatz FGIA
DUBLIN, Sept. 26, 2018 /PRNewswire/ -- The "Global Intragastric Balloons Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Intragastric Balloons Market to grow at a CAGR of 25.18% during the period 2018-2022. The report has been prepared based on an...
August 23, 2018
Obalon Therapeutics to Raise $10 Million in Private Placement
SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it has entered into a…
Report incorrect company information
Obalon Therapeutics Blogs
June 08, 2018
FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon
No Reports of Deaths Related to Use of Obalon Six-Month Balloon System SAN DIEGO – […]
Obalon Therapeutics Company Life and Culture
Report incorrect company information